<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04926714</url>
  </required_header>
  <id_info>
    <org_study_id>2021JiNanU</org_study_id>
    <nct_id>NCT04926714</nct_id>
  </id_info>
  <brief_title>Ophthalmologic Evaluation of Patients With Obesity and Metabolic Syndrome Before and After Bariatric Surgery</brief_title>
  <official_title>Ophthalmologic Evaluation of Patients With Obesity and Metabolic Syndrome Before and After Bariatric Surgery:A Pilot, Monocentric, Prospective, Open-label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>XiaoYong Liu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Jinan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the pathogenic role of obesity on blinding eye&#xD;
      diseases in a population of severely obese patients with no history of eye diseases, and to&#xD;
      verify whether weight loss induced by bariatric surgery may have a protective effect.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a pilot, monocentric, prospective, and open label study conducted at First&#xD;
      Affiliated Hospital of Jinan Universityreceived.Patients with body mass index ≥ 32.5Kg/m2; or&#xD;
      patients with body mass index of 27.5-32.5Kg/m2 and metabolic diseases were consecutively&#xD;
      recruited.All participants underwent complete ophthalmological evaluation， Keratograph 5M and&#xD;
      optical coherence tomography.Patients who underwent bariatric surgery were evaluated also 3&#xD;
      months, 6 months and 1 year after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>optical coherence tomography</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Eye Diseases</condition>
  <condition>Obesity Associated Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        1. Patients with BMI≥32.5Kg/m2Or patients with BMI27.5-32.5Kg/m2, combined with metabolic&#xD;
             diseases;&#xD;
&#xD;
          2. Subjects understand the purpose of the clinical study and are willing, able and&#xD;
             committed to return to the study center for all clinical study visits and to complete&#xD;
             all study procedures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with BMI≥32.5Kg/m2；&#xD;
&#xD;
          2. patients with BMI27.5-32.5Kg/m2, combined with metabolic diseases;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with pre-existing ocular diseases or visual alterations were excluded to&#xD;
             avoid confounding factors related to pre-existing retinal pathology, independent from&#xD;
             obesity per se.&#xD;
&#xD;
          2. Patients with dementia, Parkinson's disease, Alzheimer's disease, multiple sclerosis&#xD;
             or other severe neurological diseases were also excluded since ophthalmologic&#xD;
             parameters may be altered in these conditions.&#xD;
&#xD;
          3. Patients with lens opacities that made impossible the posterior segment examination,&#xD;
             or with a refractive error &gt; +5 or &lt;-8 diopters spherical equivalent were also&#xD;
             excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Jinan University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xiaoyong Liu</last_name>
      <phone>13760638809</phone>
      <email>jndxlxy@163.com</email>
    </contact>
    <investigator>
      <last_name>xiaoyong Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2021</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Jinan University</investigator_affiliation>
    <investigator_full_name>XiaoYong Liu</investigator_full_name>
    <investigator_title>Deputy chief physician of opthalmology, The First Affiliated Hospital of Jinan University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

